Compass Ion Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$834K Buy
3,960
+1
+0% +$214 0.07% 139
2026
Q1
$875K Sell
3,959
-5
-0.1% -$1.22K 0.08% 127
2025
Q4
$1M Buy
3,964
+3
+0.1% +$753 0.1% 110
2025
Q3
$980K Buy
3,961
+679
+21% +$163K 0.09% 114
2025
Q2
$788K Buy
3,282
+1
+0% +$233 0.09% 126
2025
Q1
$744K Buy
3,281
+598
+22% +$132K 0.09% 130
2024
Q4
$552K Sell
2,683
-115
-4% -$25.2K 0.07% 153
2024
Q3
$679K Buy
2,798
+118
+4% +$27.6K 0.08% 138
2024
Q2
$603K Hold
2,680
0.09% 130
2024
Q1
$603K Sell
2,680
-1,600
-37% -$361K 0.09% 130
2023
Q4
$941K Buy
4,280
+63
+1% +$13.3K 0.15% 96
2023
Q3
$925K Buy
+4,217
New +$954K 0.16% 91

Other funds holding STE

Compass Ion Advisors's STE Position: Q2 2026 in Review

Compass Ion Advisors increased its Steris (STE) stake by 0.03% in Q2 2026, buying an estimated $214 and bringing the position to 3,960 shares worth $834K. The position accounts for 0.07% of the portfolio, ranked #139.

Compass Ion Advisors first reported a position in STE in Q3 2023 and has held it in 12 quarters since. The position peaked at $1M in Q4 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Compass Ion Advisors held 3,960 shares of Steris worth $834K as of Q2 2026.
  • Compass Ion Advisors bought 1 Steris share in Q2 2026, an estimated $214.
  • Steris made up 0.07% of Compass Ion Advisors's portfolio in Q2 2026, its #139 holding.
  • Compass Ion Advisors first reported a position in Steris in Q3 2023 and has held it in 12 quarters since.
  • Compass Ion Advisors's Steris position peaked at $1M in Q4 2025.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Compass Ion Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.